Biogen Inc

مادة اعلانية

Latest Update: 16 Mar 2026 23:59 Abu Dhabi Time.

Market Status: Closed

BIIB

Biogen Inc

183.25

USD

1.700

0.94%

Open

182.75

Prev Close

181.55

PX_VOLUME

MARKET CAP (M)

DAY RANGE

181.98 - 184.19

52 WEEKS

110.04 - 202.41

Stock Statistics

Yearly Change

29.70%

Listed Shares (Million)

170.50

Earnings Multiple

20.66

Average 30-day trading volume

1,625,272.73

Price-to-book ratio

1.46

Earnings Per Share

8.83

Previous Dividend Distribution

Dividend Yield

0.00%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		2,279.40	2,534.70	2,645.50	2,431.00	2,454.70	2,465.80	2,464.90	2,290.50	2,386.30	2,530.30
Gross Profit		1,651.70	1,724.60	1,913.10	1,689.90	1,780.20	1,696.80	1,832.00	1,670.00	1,691.40	1,809.80
Operating Income		470.20	700.00	938.10	688.60	574.70	582.80	773.30	646.40	512.00	285.30
Net Income		-48.90	466.50	634.80	240.50	266.70	388.50	583.60	393.40	248.90	-68.30
Profit Margin		-2.15	18.40	24.00	9.89	10.86	15.76	23.68	17.18	10.43	-2.70

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		9,890.60	9,675.90	9,835.60	10,173.40	10,981.70	13,444.60
Gross Profit		7,008.50	7,080.90	7,186.00	7,985.00	8,787.60	11,410.90
Operating Income		2,816.50	2,664.30	2,150.80	3,326.30	3,588.20	4,891.30
Net Income		1,292.90	1,632.20	1,161.50	2,959.00	1,692.70	4,055.20
Profit Margin		13.07	16.87	11.81	29.09	15.41	30.16

Balance Sheet

	Period Ending:	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		29,439.50	29,207.50	28,330.20	28,033.10	28,049.30	28,313.20	26,804.10	26,567.60	26,844.80	28,193.20
Total Liabilities		11,182.70	11,000.00	10,696.20	11,054.40	11,333.30	11,954.30	10,915.00	11,354.60	12,045.40	13,713.50
Total Equity		18,256.80	18,207.50	17,634.00	16,978.70	16,716.00	16,358.90	15,889.10	15,213.00	14,799.40	14,479.70

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		29,439.50	28,049.30	26,844.80	24,554.10	23,877.30	24,618.90
Total Liabilities		11,182.70	11,333.30	12,045.40	11,165.70	12,917.60	13,932.80
Total Equity		18,256.80	16,716.00	14,799.40	13,388.40	10,959.70	10,686.10

Cash Flows Statements

	Period Ending:	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Cash From Operating Activities		511.90	1,272.50	160.90	259.30	760.90	935.60	625.80	553.20	12.50	592.40
Cash From Investing Activities		-1,231.70	-35.10	-57.00	-47.30	-18.60	-1,181.10	466.50	-66.00	-652.30	-1,742.20
Cash From Financing Activities		-137.00	-130.20	-11.70	-23.00	7.90	-6.60	-245.20	-439.60	-646.10	848.60
Net Change in Cash		-854.30	1,104.00	160.50	223.30	675.80	-209.70	834.50	24.50	-1,238.00	-329.90

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash From Operating Activities		2,204.60	2,875.50	1,547.20	1,384.30	3,639.90	4,229.80
Cash From Investing Activities		-1,371.10	-799.20	-4,101.00	1,576.60	-563.70	-608.60
Cash From Financing Activities		-301.90	-683.50	149.30	-1,747.30	-2,086.20	-5,272.70
Net Change in Cash		633.50	1,325.10	-2,369.40	1,157.90	930.20	-1,582.50

* In Million of United States Dollar

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.